The major function of frataxin is thought to be in synthesis of iron sulfur clusters. However, the unusual features of FA patients who have mutations other than GAA repeats suggest that frataxin may have other functions. In this work, Dr Lynch and his collaborators will examine cells and animals to determine if other functions of frataxin exist, whether they reflect specific parts of frataxin, and whether treatments can be derived based on these novel functions.
Award for Innovative Mindset (AIM) | Mechanism or Pathway of Disease
The N-terminus of frataxin and its role in FRDA
Grant Awarded | Aug 2025
David Lynch, MD, PhD, Jill Napierala, PhD, Yina Dong, PhD, Ian Blair, PhD
Children’s Hospital of Philadelphia, University of Texas Southwestern, University of Pennsylvania
Active
The FARA Grant Program is proud to award an Award for Innovative Mindset (AIM) to David Lynch, MD, PhD (Children’s Hospital of Philadelphia), Jill Napierala, PhD (University of Texas Southwestern), Yina Dong, PhD (Children’s Hospital of Philadelphia), and Ian Blair, PhD (University of Pennsylvania), to study the functions of frataxin.
This grant is co-sponsored by fara New Zealand.
LAY SUMMARY